Cyclafem 1/35 and Carcinoembryonic antigen increased - from FDA reports
There is no Carcinoembryonic antigen increased reported by people who take Cyclafem 1/35 yet. This review analyzes which people have Carcinoembryonic antigen increased with Cyclafem 1/35. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Mar, 25, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Carcinoembryonic antigen increased when taking Cyclafem 1/35?
- Check symptoms - is carcinoembryonic antigen increased caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- More tools...
Cyclafem 1/35 has active ingredients of ethinyl estradiol; norethindrone. It is often used in birth control. (latest outcomes from Cyclafem 1/35 135 users)
Carcinoembryonic Antigen Increased
Carcinoembryonic antigen increased has been reported by people with colon cancer, breast cancer, breast cancer metastatic, high blood pressure, metastases to bone (latest reports from 920 Carcinoembryonic antigen increased patients).